Strategic Blueprint LLC raised its holdings in MetLife, Inc. (NYSE:MET – Free Report) by 7.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,060 shares of the financial services provider’s stock after purchasing an additional 202 shares during the period. Strategic Blueprint LLC’s holdings in MetLife were worth $251,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. MeadowBrook Investment Advisors LLC increased its position in MetLife by 244.4% during the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after buying an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. increased its position in MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 186 shares in the last quarter. Wolff Wiese Magana LLC raised its stake in MetLife by 374.3% in the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 277 shares during the last quarter. Peterson Financial Group Inc. purchased a new position in MetLife in the 3rd quarter valued at about $30,000. Finally, Retirement Wealth Solutions LLC acquired a new stake in shares of MetLife during the 4th quarter worth about $32,000. 94.99% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of equities analysts have recently weighed in on the stock. Wells Fargo & Company cut their price objective on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating for the company in a research report on Tuesday, January 14th. StockNews.com lowered MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. JPMorgan Chase & Co. lifted their price objective on MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. Barclays increased their target price on MetLife from $90.00 to $96.00 and gave the stock an “overweight” rating in a research report on Monday, January 6th. Finally, BMO Capital Markets started coverage on MetLife in a report on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 price target for the company. Two research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, MetLife presently has a consensus rating of “Moderate Buy” and a consensus price target of $90.46.
MetLife Stock Down 0.5 %
Shares of MetLife stock opened at $86.56 on Friday. MetLife, Inc. has a twelve month low of $64.61 and a twelve month high of $89.05. The stock has a market cap of $59.93 billion, a price-to-earnings ratio of 17.45, a price-to-earnings-growth ratio of 0.66 and a beta of 1.07. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. The company has a fifty day moving average price of $84.06 and a 200 day moving average price of $80.48.
MetLife Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be issued a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, February 4th. This represents a $2.18 annualized dividend and a dividend yield of 2.52%. MetLife’s payout ratio is currently 43.95%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- Most Volatile Stocks, What Investors Need to Know
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- Growth Stocks: What They Are, What They Are Not
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- Insider Trades May Not Tell You What You Think
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.